NanoViricides
NNVC
#10112
Rank
$23.75 M
Marketcap
$1.32
Share price
-3.65%
Change (1 day)
-10.81%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: $23.75 Million USD

As of December 2025 NanoViricides has a market cap of $23.75 Million USD. This makes NanoViricides the world's 10112th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025$23.75 M10.39%
2024$21.52 M79.62%
2023$11.98 M-7.03%
2022$12.88 M-69.94%
2021$42.87 M40.07%
2020$30.6 M215.06%
2019$9.71 M-30.11%
2018$13.9 M-75.06%
2017$55.74 M-10.5%
2016$62.27 M-8.73%
2015$68.23 M-55.65%
2014$0.15 B-35.95%
2013$0.24 B221.02%
2012$74.82 M-17.87%
2011$91.1 M-55.35%
2010$0.20 B81.97%
2009$0.11 B12.81%
2008$99.39 M113.89%
2007$46.46 M

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of NanoViricides was reported to be:

$24.47 Million USD
by Nasdaq info icon info icon
$24.65 Million USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioCryst Pharmaceuticals
BCRX
$1.61 B 6,688.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$1.09 B 4,510.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$150.55 B 633,673.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$104.25 B 438,739.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$243.83 B 1,026,306.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$97.78 B 411,519.86%๐Ÿ‡ฌ๐Ÿ‡ง UK